[Therapeutic Purpose and Treatment Guideline of Osteoporosis]

Overview

Journal Clin Calcium

Specialty Endocrinology

Date 2012 Jun 2

PMID 22653029

Citations 2

Authors

Sumito Ogawa

Yasuyoshi Ouchi

Affiliations

Soon will be listed here.

Abstract

The purpose of osteoporosis treatment is mainly for maintenance of bone health and QOL as well as for fracture prevention, and pharmacological intervention, improvement of risk factors including lifestyle, utilization of FRAX® are important in practice. Recently, treatment guideline of osteoporosis is revised in the Japanese guidelines for the prevention and treatment of osteoporosis.

Citing Articles

Gene Polymorphisms and the Bone Mineral Density Response to Alendronate Therapy in Postmenopausal Chinese Women with Low Bone Mass.

Zhao J, Liu L, Lv S, Wang C, Yue H, Zhang Z Pharmgenomics Pers Med. 2022; 14:1669-1678.

PMID: 34992429 PMC: 8711734. DOI: 10.2147/PGPM.S344818.

Genetic polymorphisms in the mevalonate pathway affect the therapeutic response to alendronate treatment in postmenopausal Chinese women with low bone mineral density.

Wang C, Zheng H, He J, Zhang H, Yue H, Hu W Pharmacogenomics J. 2014; 15(2):158-64.

PMID: 25223561 DOI: 10.1038/tpj.2014.52.